Healthcare Services

Global Diabetic Kidney Disease Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Diabetic Kidney Disease Market In 2026 And What Value Is Projected For 2030?

The diabetic kidney disease market has witnessed strong expansion recently. It is forecast to grow from $2.8 billion in 2025 to $2.96 billion in 2026, at a compound annual growth rate (CAGR) of 5.9%. This past growth can be attributed to the high prevalence of diabetes-related kidney damage, diagnoses occurring at late stages of the disease, insufficient adoption of early screening, dependence on dialysis in advanced cases, and an increase in hospitalization rates.

The diabetic kidney disease market size is anticipated to experience robust expansion over the coming years. This market is projected to reach $3.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. Several factors are driving this expansion during the projection period, including breakthroughs in renal protective medications, a rise in early diagnostic efforts, the increasing prevalence of chronic kidney disease, wider availability of specialized nephrology services, and an emphasis on tailored treatment plans. Key developments anticipated in this period encompass the broader implementation of early renal screening, a surge in renoprotective drug treatments, the development of combined therapeutic strategies, a heightened commitment to slowing disease progression, and the incorporation of collaborative care approaches across various medical disciplines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Diabetic Kidney Disease Market?

The increasing occurrence of chronic kidney disease is anticipated to boost the expansion of the diabetic kidney disease market. Chronic kidney disease (CKD) is defined as a persistent condition leading to the gradual decline of kidney function over time, causing complications such as high blood pressure, anemia, and bone diseases. Addressing these chronic kidney diseases necessitates various diagnostic and therapeutic approaches, thereby stimulating the growth of the diabetic kidney disease market. For example, as reported by the Kidney Research UK in June 2023, approximately 7.2 million individuals in the United Kingdom suffer from chronic kidney disease (CKD), representing over 10% of the populace. Of these, 3.25 million are in advanced stages, while roughly 3.9 million are in early, often undiagnosed and symptom-free, stages. Forecasts suggest that the total number of people with chronic renal disease in the United Kingdom could reach 7.61 million by 2033. Consequently, the escalating prevalence of chronic kidney disease is propelling the expansion of the diabetic kidney disease market.

What Are The Key Segments Of The Diabetic Kidney Disease Market?

The diabetic kidney disease market covered in this report is segmented –

1) By Type: Type 1 Diabetes, Type 2 Diabetes

2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments

3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Type 1 Diabetes: Autoimmune-Related Diabetic Kidney Disease, Early-Onset Diabetic Kidney Disease

2) By Type 2 Diabetes: Obesity-Related Diabetic Kidney Disease, Late-Onset Diabetic Kidney Disease

What Trends Are Projected To Affect The Diabetic Kidney Disease Market?

Leading firms within the diabetic kidney disease market are prioritizing the adoption of sophisticated tools, including artificial intelligence (AI)-enabled prognostic platforms, aiming to improve early identification of risk, tailored disease approaches, and sustained patient health results. These AI-powered prognostic platforms serve as diagnostic instruments, integrating blood biomarker data with machine-learning algorithms to forecast the potential for worsening kidney function, thereby facilitating features like calculating risk scores, categorizing patients, and formulating plans for early clinical action. An example of this is in June 2023, when Renalytix plc, a diagnostics company from the UK, obtained U.S. Food and Drug Administration (FDA) De Novo marketing approval for KidneyIntelX.dkd, an AI-powered prognostic platform specifically developed to evaluate the risk of substantial kidney function reduction in adults living with type 2 diabetes and nascent chronic kidney disease. This platform incorporates machine-learning algorithms integrated with biomarkers, alongside cloud-based integration for workflow, and provides reports on stratified risk. KidneyIntelX.dkd contributes to better clinical choices, aids in focused monitoring strategies, and bolsters proactive care arrangements.

Who Are The Leading Companies Operating In The Diabetic Kidney Disease Market?

Major companies operating in the diabetic kidney disease market are AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited

Read the full diabetic kidney disease market report here:

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

What Are The Leading Geographic Regions In The Diabetic Kidney Disease Market?

North America was the largest region in the diabetic kidney disease market in 2025. The regions covered in the diabetic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Diabetic Kidney Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9932&type=smp

Browse Through More Reports Similar to the Global Diabetic Kidney Disease Market 2026, By The Business Research Company

Kidney Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Chronic Kidney Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Rare Kidney Diseases Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795